Adding to the now lengthy list of broadly neutralizing antibodies is the recently discovered antibody N6. This one tops the list in terms of neutralizing breadth-knocking out 98 percent of HIV isolates -and also packs a potent anti-viral punch.
The 24th Conference on Retroviruses and Opportunistic Infections, which took place from February 13-16, is the preeminent US-based scientific meeting on HIV research.
Long-time pharmaceutical company veteran Emilio Emini took over the reins of the HIV program at the Bill & Melinda Gates Foundation over a year ago. Here, he describes the Foundation's efforts to combat HIV and why this task is more important than ever.
Talent-rich but comparatively resource-poor and under intense political pressure, the European Union launches a pair of research initiatives under a E45 million umbrella.
The Ugandan physician and global health champion Alex Coutinho talks about his career in HIV/AIDS and his belief in the importance of a vaccine.
The Centre for the Aids Programme of Research in Sourt Agrica, CAPRISA, has been working to unlock the secrets and weaknesses of HIV and TB for years. With a spate of ongoing and planned trials, researchers hope to soon turn the tables on the deadly diseases.
